Form 4: Shirley Weis Transfers Pediatrix Medical Group Shares to Family Trust

Sentiment:

SEC Form 4 Filing


Director Shirley Weis transferred 17,668 shares of Pediatrix Medical Group, Inc. common stock to a family trust on February 25, 2025.

Summary

  • On February 25, 2025, Shirley Weis, a director of Pediatrix Medical Group, Inc., transferred 17,668 shares of common stock to The Weis Family Trust.
  • Following the transaction, Ms. Weis directly owns 18,360 shares of Pediatrix Medical Group, Inc.
  • The Weis Family Trust, of which Ms. Weis and her husband are trustees, now indirectly holds 17,668 shares.
  • The beneficiaries of the trust are members of Ms. Weis' immediate family.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing regarding a stock transfer. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a routine Form 4 filing, reflecting a change in beneficial ownership due to a transfer of shares to a family trust. Such transactions are common among corporate insiders and do not necessarily indicate a change in the director's outlook on the company.

Related Party Transactions

  • The transfer of shares to The Weis Family Trust, of which Shirley Weis is a trustee and her family members are beneficiaries, constitutes a related party transaction.

Stakeholder Impact

  • The transaction has minimal direct impact on stakeholders, as it is a transfer of shares to a family trust and does not involve a sale to the public market.

Key Dates

DateDescription
02/25/2025Date of the stock transfer to the family trust
02/26/2025Date of signature by Attorney-in-Fact

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.